Faith L. Charles's most recent trade in Abeona Therapeutics Inc was a trade of 10,738 Common Stock done at an average price of $5.9 . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Faith L. Charles | Director | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 10,738 | 139,094 (0%) | 0% | 5.9 | 62,879 | Common Stock |
| Conduit Pharmaceuticals Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.87 per share. | 16 Apr 2025 | 115,194 | 165,238 | - | 0.9 | 100,000 | Common Stock |
| Conduit Pharmaceuticals Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.89 per share. | 30 Mar 2025 | 46,629 | 50,044 | - | 0.9 | 41,500 | Common Stock |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 149,832 (0%) | 0% | 0 | Common Stock | |
| Conduit Pharmaceuticals Inc | Faith L. Charles | Director | 18 Dec 2024 | 420,000 | 420,000 | - | - | Stock Option (Right to Buy) | ||
| Conduit Pharmaceuticals Inc | Faith L. Charles | Director | 18 Nov 2024 | 266,594 | 341,594 | - | 0.1 | 24,500 | Common Stock | |
| Conduit Pharmaceuticals Inc | Faith L. Charles | Director | 18 Nov 2024 | 75,000 | 75,000 | - | - | Common Stock | ||
| Avenue Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 30,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 113,731 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 101,934 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 26 Apr 2024 | 7,550 | 78,323 (0%) | 0% | 3.3 | 24,764 | Common Stock |
| Cns Pharmaceuticals Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 64,815 | - | - | Restricted Stock Units | |
| Cns Pharmaceuticals Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 47,315 | - | - | Option to purchase common stock | |
| Avenue Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 79,103 (0%) | 0% | 4.6 | 271,143 | Common Stock |
| Cns Pharmaceuticals Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 3,500 | 3,500 | - | - | Option to purchase common stock | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 20,414 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 98,168 | 98,168 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 77,181 | 77,181 (0%) | 0% | 0 | Common Stock |